Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilson Lam

Showing results (41-50 of 118) with videos related to

Pageof 12
Sort By:
European Journal of Haematology|September 13, 2019
Reduced-intensity conditioning allogeneic transplant with dual T-cell depletion in myelofibrosisMaria Queralt Salas, Wilson Lam, Arjun Datt Law, et al.
European Journal of Haematology|August 17, 2019
Impact of central nervous system involvement in AML on outcomes after allotransplant and utility of pretransplant cerebrospinal fluid assessmentShruti Prem, Eshetu G Atenafu, Jose Avena, et al.
Tropical Medicine and Infectious Disease|October 3, 2018
Melioidosis in Hong KongGrace Lui, Anthony Tam, Eugene Y K Tso, et al.
European Journal of Haematology|January 31, 2022
Allogeneic hematopoietic stem cell transplantation in patients with therapy-related hematologic malignancies developing after multiple myelomaRam Vasudevan Nampoothiri, Ivan Pasic, Arjun Datt Law, et al.
European Journal of Haematology|March 30, 2019
Low rates of acute and chronic GVHD with ATG and PTCy in matched and mismatched unrelated donor peripheral blood stem cell transplantsShruti Prem, Eshetu G Atenafu, Zeyad Al-Shaibani, et al.
Transplantation and Cellular Therapy|June 13, 2025
Association of Cyclosporine Exposure Post-Allogeneic Hematopoietic Cell Transplant with Graft Failure and Relapse Risk in Hematological MalignanciesAhmed Alnughmush, Mats Remberger, Vathany Kulasingam, et al.
European Journal of Haematology|October 4, 2021
Anti-thymocyte globulin and post-transplant cyclophosphamide predisposes to inferior outcome when using cryopreserved stem cell graftsIgor Novitzky-Basso, Mats Remberger, Carol Chen, et al.
Hematology/Oncology and Stem Cell Therapy|August 15, 2023
A Single-center, Real-world Experience of Chronic GVHD Treatment Using Ibrutinib, Imatinib, and Ruxolitinib and its Treatment OutcomesSwe M Linn, Igor Novitzky-Basso, Omar Abduljalil, et al.
European Journal of Haematology|March 3, 2020
Outcomes of therapy-related acute lymphoblastic leukemia in adults after allogeneic stem cell transplantationRam Vasudevan Nampoothiri, Arjun Datt Law, Wilson Lam, et al.
Hematology/Oncology and Stem Cell Therapy|March 29, 2021
Predictors of Outcomes of Therapy-Related Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell TransplantationRam Vasudevan Nampoothiri, Arjun Datt Law, Wilson Lam, et al.
Pageof 12

Showing results (41-50 of 118) with videos related to

Sort By:
Pageof 12
European Journal of Haematology|September 13, 2019
Reduced-intensity conditioning allogeneic transplant with dual T-cell depletion in myelofibrosisMaria Queralt Salas, Wilson Lam, Arjun Datt Law, et al.
European Journal of Haematology|August 17, 2019
Impact of central nervous system involvement in AML on outcomes after allotransplant and utility of pretransplant cerebrospinal fluid assessmentShruti Prem, Eshetu G Atenafu, Jose Avena, et al.
Tropical Medicine and Infectious Disease|October 3, 2018
Melioidosis in Hong KongGrace Lui, Anthony Tam, Eugene Y K Tso, et al.
European Journal of Haematology|January 31, 2022
Allogeneic hematopoietic stem cell transplantation in patients with therapy-related hematologic malignancies developing after multiple myelomaRam Vasudevan Nampoothiri, Ivan Pasic, Arjun Datt Law, et al.
European Journal of Haematology|March 30, 2019
Low rates of acute and chronic GVHD with ATG and PTCy in matched and mismatched unrelated donor peripheral blood stem cell transplantsShruti Prem, Eshetu G Atenafu, Zeyad Al-Shaibani, et al.
Transplantation and Cellular Therapy|June 13, 2025
Association of Cyclosporine Exposure Post-Allogeneic Hematopoietic Cell Transplant with Graft Failure and Relapse Risk in Hematological MalignanciesAhmed Alnughmush, Mats Remberger, Vathany Kulasingam, et al.
European Journal of Haematology|October 4, 2021
Anti-thymocyte globulin and post-transplant cyclophosphamide predisposes to inferior outcome when using cryopreserved stem cell graftsIgor Novitzky-Basso, Mats Remberger, Carol Chen, et al.
Hematology/Oncology and Stem Cell Therapy|August 15, 2023
A Single-center, Real-world Experience of Chronic GVHD Treatment Using Ibrutinib, Imatinib, and Ruxolitinib and its Treatment OutcomesSwe M Linn, Igor Novitzky-Basso, Omar Abduljalil, et al.
European Journal of Haematology|March 3, 2020
Outcomes of therapy-related acute lymphoblastic leukemia in adults after allogeneic stem cell transplantationRam Vasudevan Nampoothiri, Arjun Datt Law, Wilson Lam, et al.
Hematology/Oncology and Stem Cell Therapy|March 29, 2021
Predictors of Outcomes of Therapy-Related Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell TransplantationRam Vasudevan Nampoothiri, Arjun Datt Law, Wilson Lam, et al.
Pageof 12